Figure 2From: Interfacing medicinal chemistry with structural bioinformatics: implications for T box riboswitch RNA drug discoveryT box drug discovery goal. As soon as the antiterminator is transcribed (a), a small molecule ligand competes with tRNA for binding the antiterminator (b), but does not overly stabilize the antiterminator such that the terminator can form and transcription is terminated (c).Back to article page